Singapore-headquartered iNova Pharmaceuticals will buy a portfolio of consumer healthcare brands from Sackler-owned Mundipharma International for an enterprise value of $540 million, an iNova spokesperson said earlier this week....
According to Manav Teli, executive director of Lord's Mark Industries, government interventions such as streamlining regulatory processes, offering research and development grants, and facilitating partnerships between manufacturers...
Akums announced the approval of perampanel oral suspension by the Drug Controller General of India (DCGI). The perampanel oral suspension is a bioequivalent formulation to the US FDA-approved FYCOMPA (perampanel) oral suspension...
The U.S. Food and Drug Administration has approved RYSTIGGO for the treatment of generalised myasthenia gravis in adult patients who have anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibody positivity, according to UCB...
InSilicoTrials, a top supplier of artificial intelligence (AI) and simulation tools for drug and medical device development, and COSBI, a premier systems biology research centre, have forged a ground-breaking strategic partnership with the aim of...
Anju Software, a top supplier of life science technologies, stated that TrialMaster and Anju's eClinical Suite will help ClinChoice grow its market share. Through the cooperation, ClinChoice is able to offer a complete line of flexible, affordable...
Driving change from the ground up, the eGov Foundation today announced the launch of 23 transformative 10BedICU Projects in Assam in the presence of The Hon'ble Chief Minister of Assam, Shri Himanta Biswa Sarma, and the Hon'ble Health Minister, ....
Zydus Lifesciences, a discovery-driven global life sciences company, has acquired a 6.5% stake in Mylab Discovery Solutions from Rising Sun Holdings, an investment company owned by Adar Poonawalla, through its wholly owned subsidiary Zydus Animal...
BioCityBiopharma, a clinical-stage biopharmaceutical company, announced the start of a randomised, placebo-controlled phase 2 clinical trial of SC0062, a novel oral endothelin A (ETA)-receptor selective antagonist, in China (NCT05687890)....
Global pharmaceutical company Dr Reddy's Laboratories Ltd. today announced its entry into the trade generics business in India with the launch of its new dedicated division, "RGenX." Through this, the pharmaceutical company aims to give patients...
, CDSCO.jpg)
